The pharmacotherapy of alcohol dependence: Clinical and economic aspects

Economics of Neuroscience

Volumn 3, Issue 12, 2001, Pages 62-66

  Swift, Robert M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CLOZAPINE; DISULFIRAM; HALOPERIDOL; NALTREXONE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY NEUROSIS; ARTICLE; AUSTRALIA; BIRTH DEFECT; CEREBROVASCULAR DISEASE; CHILD ABUSE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DETOXIFICATION; DIABETES MELLITUS; DRINKING BEHAVIOR; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG COST; ECONOMIC ASPECT; FAMILY VIOLENCE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH SURVEY; HEART DISEASE; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; MENTAL DISEASE; MORBIDITY; MORTALITY; PATIENT COUNSELING; PREVALENCE; PSYCHOTHERAPY; QUALITY OF LIFE; SCHIZOPHRENIA; SELF HELP; TRAFFIC ACCIDENT; TREATMENT OUTCOME; UNITED STATES;

EID: 0035723237     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Comorbidity of mental disorders with alcohol and other drug abuse
2. Exposure to alcoholism in the family; U.S., 1988
3. Prevalence, detection and treatment of alcoholism in hospitalized patients
4. Alcohol-related hospitalizations of elderly people: Prevalence and geographic variation in the United States
5. The effectiveness of inpatient and outpatient treatment for alcohol abuse: The need to focus on mediators and moderators of setting effects
6. Costs of alcoholism treatment: A first approximation
7. Pharmacotherapies for alcoholism: Promising agents and clinical issues
8. Conference summary: Consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment
9. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence
10. Recent developments in disulfiram treatment
11. Disulfiram treatment of alcoholism
12. Disulfiram in the treatment of alcoholism
13. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
14. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
15. Techniques to enhance compliance with disulfiram
16. Disulfiram (Antabuse) contracts in treatment of alcoholism
17. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking Macaque monkey
18. Naltrexone blocks the post-shock increase of alcohol consumption
19. Excess of drinking related to excess activity of opioid systems
20. Naltrexone in the treatment of alcohol dependence
21. Naltrexone and coping skills therapy for alcohol dependence
22. Drug treatment of alcohol dependence
23. Pharmacological treatment of alcohol dependence. A review of the evidence
24. Acomprosate modulates synaptosomal GABA transmission in chronically alcoholised rats
25. Acamprosate (calcium acetylhomotaurine) decreases postsynaptic potentials in rat neocortex: Possible involvement of excitatory amino acid receptors
26. Lack of effects of Ca-acetyl homotaurine on chronic and acute toxicities of alcohol in the rat
27. Acamprosate: From pharmacology to therapeutics
28. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
29. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence
30. The co-occurrence of alcoholism with other psychiatric disorders
31. Life time co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey
32. The self-medication hypothesis of addictive disorders
33. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression
34. Imipramine treatment of alcoholics with primary depression: A placebo controlled clinical trial
35. Fluoxetine in depressed alcoholics: A double-blind placebo-controlled trial
36. Alcohol dependence and anxiety disorders: What is the relationship?
37. Buspirone treatment of anxious alcoholics. A placebo-controlled trial
38. A placebo-controlled trial of buspirone in anxious inpatient alcoholics
39. Decreased substance use in chronically psychotic patients treated with clozapine
40. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia
41. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects
42. Olanzapine reduces cue-elicited craving for alcohol among heavy social drinkers
43. Cost benefits of substance abuse treatment: An overview of results from alcohol and drug abuse
44. Impact of alcoholism treatment on total health care costs: A six-year study
45. The reduction of health care costs associated with alcoholism treatment: A 14 year longitudinal study
46. Medical care utilization as a function of recovery status following chemical addictions treatment
47. Actual and estimated replication costs for alcohol treatment modalities: Case study from Project MATCH
48. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) study
49. Economic evaluation of Campral (acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients
50. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
51. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial